GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » Pre-Tax Income

Universal Ibogaine (TSXV:IBO) Pre-Tax Income : C$-1.19 Mil (TTM As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Universal Ibogaine Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Universal Ibogaine's pretax income for the three months ended in Jan. 2024 was C$-0.22 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jan. 2024 was C$-1.19 Mil. Universal Ibogaine's pretax margin was -37.69%.

During the past 7 years, Universal Ibogaine's highest Pretax Margin was -53.35%. The lowest was -980.02%. And the median was -606.03%.


Universal Ibogaine Pre-Tax Income Historical Data

The historical data trend for Universal Ibogaine's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine Pre-Tax Income Chart

Universal Ibogaine Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Jul22 Jul23
Pre-Tax Income
Get a 7-Day Free Trial -0.10 -0.12 -0.29 -10.50 -2.39

Universal Ibogaine Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.79 -0.49 -0.27 -0.21 -0.22

Competitive Comparison of Universal Ibogaine's Pre-Tax Income

For the Biotechnology subindustry, Universal Ibogaine's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Universal Ibogaine's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Universal Ibogaine's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Universal Ibogaine's Pre-Tax Income falls into.



Universal Ibogaine Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Universal Ibogaine's Pretax Income for the fiscal year that ended in Jul. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-2.051+-0.186+-0.153+0+0
=-2.39

Universal Ibogaine's Pretax Income for the quarter that ended in Jan. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-0.186+0.006+-0.041+0+-0.001
=-0.22

Pre-Tax Income for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.19 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Universal Ibogaine  (TSXV:IBO) Pre-Tax Income Explanation

Universal Ibogaine's Pretax Margin for the quarter that ended in Jan. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-0.222/0.589
=-37.69%

During the past 7 years, Universal Ibogaine's highest Pretax Margin was -53.35%. The lowest was -980.02%. And the median was -606.03%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Universal Ibogaine Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Universal Ibogaine's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Universal Ibogaine (TSXV:IBO) Business Description

Traded in Other Exchanges
Address
400 3rd Avenue South west, Suite 1470, Calgary, AB, CAN, T2P 4H2
Universal Ibogaine Inc develops a platform of addiction treatment clinics, which use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. It runs addiction clinics it has a research partner clinic in Mexico.
Executives
Ian Rabb Senior Officer

Universal Ibogaine (TSXV:IBO) Headlines

No Headlines